Searchable abstracts of presentations at key conferences in endocrinology

ea0105oc3 | Oral Communications | UKINETS2024

Emergency and routine presentation of neuroendocrine neoplasia in England: determinants of diagnosis and survival outcomes

Line El Asmar Marie , Mortagy Mohamed , White Benjamin , Chandrakumaran Kandiah , Burns Dan , Ramage John

Introduction: The mean time from onset of symptoms to diagnosis in NEN is around 5-7 years. Late stage NEN is often diagnosed during an emergency admission. The difference in overall survival (OS) between emergency and elective diagnoses has not been studied. This study assesses factors associated with emergency presentation (EP) versus routine presentation (RP), evaluates factors associated with late presentation, and correlates these with OS. Methods: ...

ea0105p19 | Poster Presentations | UKINETS2024

Systemic anti-cancer therapy in gastroenteropancreatic neuroendocrine carcinoma (GEP-NEC): insights from national cancer registration and analysis service (NCRAS)

Mortagy Mohamed , Line El Asmar Marie , Paisey Sangeeta , E White Benjamin , Chandrakumaran Kandiah , Srirajaskanthan Rajaventhan , Ramage John

Introduction: European Neuroendocrine Tumour Society guidelines advocate the use of platinum-based chemotherapy in combination with Etoposide as first line chemotherapy in advanced GEP-NEC. Following this regime, 30% of digestive NEC and 60% of colorectal NEC showed a lack of benefit or evidence of disease progression. Available retrospective evidence is from small studies. Other studies have shown BMI relates to survival in NEN. This study aims at studying chemotherapy regime...